Connect Biopharma Holdings annual return on equity
2021
2022
2023
2024
2025
Connect Biopharma Holdings Return on Equity (ROE) Growth & History (CNTB)
Connect Biopharma Holdings's return on equity was −82.72% for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −82.72% | −66.58 pp |
| 2024 | 2024-12-31 | −16.14% | +31.65 pp |
| 2023 | 2023-12-31 | −47.79% | +7.05 pp |
| 2022 | 2022-12-31 | −54.84% | +296.39 pp |
| 2021 | 2021-12-31 | −351.23% | — |
Connect Biopharma Holdings quarterly return on equity
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −49.75% | −33.02 pp |
| Q1 2026 | 2026-03-31 | −45.86% | −34.12 pp |
| Q4 2025 | 2025-12-31 | −31.04% | −22.27 pp |
| Q3 2025 | 2025-09-30 | −27.15% | — |
| Q2 2025 | 2025-06-30 | −16.73% | −30.70 pp |
| Q1 2025 | 2025-03-31 | −11.74% | — |
| Q4 2024 | 2024-12-31 | −8.77% | — |
| Q2 2024 | 2024-06-30 | 13.98% | — |
Connect Biopharma Holdings return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's return on equity increased from −351.23% to −82.72%, a change of +268.51 percentage points. The latest reported quarter, Q2 2026, shows −49.75%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings source filings ↗